BNTX

BioNTech SE - ADR

101.50

USD

BNTX Earnings Reports

Positive Surprise Ratio

BNTX beat 17 of 25 last estimates.

68%

Next Report

Tomorrow BMO

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$810.40M

-$0.03

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-31.90%

-102.78%

BioNTech SE - ADR earnings per share and revenue

On --, BNTX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.03 USD, with revenue projected to reach 810.40 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Liquidia Corporation Common Stock

Report Date

Mar 05, 2026 For Q4 25

Estimate

$0.18

Actual

$0.15

Surprise

-18.48%

EyePoint, Inc. Common Stock

Report Date

Mar 04, 2026 For Q4 25

Estimate

-$0.76

Actual

-$0.81

Surprise

-6.20%

Kura Oncology, Inc.

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.62

Actual

-$0.92

Surprise

-47.84%

CorMedix Inc.

Report Date

Mar 05, 2026 For Q4 25

Estimate

$0.83

Actual

$0.61

Surprise

-26.73%

REGENXBIO Inc.

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.97

Actual

-$1.30

Surprise

-33.31%

Lexicon Pharmaceuticals, Inc.

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.07

Actual

-$0.04

Surprise

+43.18%

Contineum Therapeutics, Inc. Class A Common Stock

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.41

Actual

-$0.49

Surprise

-18.41%

Lineage Cell Therapeutics, Inc.

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.05

Actual

$0.00

Surprise

+100.00%

Atea Pharmaceuticals, Inc. Common Stock

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$0.54

Actual

-$0.56

Surprise

-5.44%

Aligos Therapeutics, Inc. Common Stock

Report Date

Mar 05, 2026 For Q4 25

Estimate

-$1.88

Actual

-$1.91

Surprise

-1.11%

FAQ

What were BioNTech SE - ADR's earnings and revenue for the latest quarter Q-- --?

For Q-- --, BioNTech SE - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to BioNTech SE - ADR's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is BioNTech SE - ADR expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for BioNTech SE - ADR's next earnings report?

Based on 18 analysts, BioNTech SE - ADR is expected to report EPS of -$0.03 and revenue of $810.40M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.